News & Analysis on Clinical Trial Services & Contract Research And Development
Brexit: Indian firms worried but Big Pharma and EMA remain positive for now
Indian companies in the UK are among many in the pharma industry facing an uncertain future after Britain voted to exit the single-market last week.
Also: Qiagen completes tender offer for Exiqon
Agilent Technologies has acquired the assets of a cloud-based laboratory management software firm.
Charles River Laboratories has acquired Blue Stream Laboratories, expanding the company’s biologic and biosimilar development capabilities.
The Swiss drugs regulator saw a near-doubling in the number of inspections prompted by complaints or suspected infringements in 2015, according to its latest annual report.
DIA 2016
endpoint has introduced its new clinical supply management tool DRIVE, which enables interactive response technology (IRT) functionality for non-IRT and investigator-sponsored trials.